Comparative Acute Cochlear Toxicity of Intravenous Bumetanide and Furosemide in the Purebred Beagle
Author:
- 12 November 1981
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (11) , 620-627
Abstract
Comparisons were made of the effects of various doses of intravenous bumetanide and furosemide on the primary auditory afferent activity (N1) and cochlear microphonics (CM) of beagles. The dose‐response relationships of the N1 depressions to bumetanide and furosemide are parallel; those of the CM depressions are also parallel but have a much shallower slope than those of the N1 depressions. With both drugs, N1 depression occurs at lower doses than does CM depression. The N1 depression produced by a particular dose of bumetanide or furosemide bore a linear relationship to the CM depression produced. This finding supports the postulate that the cochlear site and mechanism of ototoxic action of the loop diuretics are directed at an earlier step of the cochlear transduction process than N1. Using N1 depression as the gross electrophysiologic index of ototoxicity, the acute ototoxic potency of bumetanide in beagles is approximately 6.5 times that of furosemide, whereas its diuretic potency is 40 to 60 times that of furosemide. Therefore, when clinical dosages of the two drugs are considered, the relative acute ototoxic potency of bumetanide in the beagle is 0.11 to 0.16 that of furosemide. This range is identical to the relative ototoxic potency of 0.11 to 0.16 previously obtained in the cat. Serum concentrations of bumetanide and furosemide increased linearly with the doses of the two drugs, except for the highest dose given (100 mg/kg for both drugs). The serum concentrations at that dose of both drugs are less than the mathematically predicted values. Histologic (light‐microscopic) examination of the cochleas did not reveal any significant pathology.Keywords
This publication has 9 references indexed in Scilit:
- Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagleToxicology and Applied Pharmacology, 1979
- Pharmacology of Hearing and OtotoxicityAnnual Review of Pharmacology and Toxicology, 1978
- Effect of bumetanide on the positive endocochlear dc potential of the catToxicology and Applied Pharmacology, 1976
- Production of cochlear potentials by inner and outer hair cellsThe Journal of the Acoustical Society of America, 1976
- FRUSEMIDE, BUMETANIDE, AND OTOTOXICITYThe Lancet, 1976
- Cochlear N1 depression produced by the new “loop” diuretic, bumetanide, in catsNeuropharmacology, 1975
- Comparison of the cochlear toxicity of sodium ethacrynate, furosemide, and the cysteine adduct of sodium ethacrynate in catsToxicology and Applied Pharmacology, 1975
- Neuroanatomical basis of cochlear coding mechanismsInternational Journal of Audiology, 1975
- THE EFFECTS OF SELECTED CHOLINERGIC DRUGS AND STRYCHNINE ON COCHLEAR RESPONSES AND OLIVO-COCHLEAR INHIBITIONThe Journal of Pharmacology and Experimental Therapeutics, 1969